This chapter describes the market for pharmaceuticals, which exceeded $500 million in sales in 2010. The industry is …

this paper, we take a close look at competition among the generic entrants during the first three years after patent … expiration and examine whether there is a first mover advantage. We specify a random effect nested logit model of competition … that allows for competition between the brand drug and generics, and among multiple generic drugs. The model accommodates …

model to study consumers’ buying behavior and firm competition in the post patent ethical drug markets. We use the estimated …

We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using …-savings, and that patients' copayments decrease despite the extra surcharges under RP. -- pharmaceuticals ; regulation ; generic … competition …

We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using …

competition from a third firm offering a generic version perceived to be of lower quality. This model allows us to compare generic … reference pricing (GRP), therapeutic reference pricing (TRP), and no reference pricing (NRP). We show that competition is …